SecBot SecBot

ORGN

Origin Materials, Inc.
Nasdaq· Industrial Organic Chemicals· Inc. DE· CIK 0001802457 Biotech & Drug Discovery
—
Market cap
$5.2M
Nano cap
Next earnings
Nov 11
in 16 days
Short interest
206.3K
≈3.8% of shares · −32.7%
Days to cover
1.9
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·Next Earnings date, Nov 11, 2026

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 3 added (0 new), 5 trimmed or exited.

  • Short sellersCOVERING

    Short interest −32.7% to 206.3K shares. 1.9 days to cover, ≈3.8% of shares.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
ROYAL BANK OF CANADAADD11—
VANGUARD CAPITAL MANAGEMENT LLCTRIM45,892$45.4K
CITADEL ADVISORS LLCDOUBLED33,828$33.5K
GOLDMAN SACHS GROUP INCNEAR_EXIT16,896$16.7K
UBS Group AGTRIM5,677$5.6K
GROUP ONE TRADING LLCTRIM466$461.00
JONES FINANCIAL COMPANIES LLLPTRIM286$248.00
BARCLAYS PLCDOUBLED39$39.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Aug 2024
Recent actions
DateFirmActionRating
Aug 16, 2024B of A Securities
UPGRADE
UPGRADEBuy
Aug 11, 2023Craig-Hallum
DOWNGRADE
DOWNGRADEHold
Aug 10, 2023Credit Suisse
MAINTAIN
MAINTAINOutperform
Oct 14, 2022Credit Suisse
INITIATE
INITIATEOutperform
Mar 1, 2022Goldman Sachs
MAINTAIN
MAINTAINNeutral
Jan 6, 2022B of A Securities
UPGRADE
UPGRADEBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Mar 4, 2026
Lee Joshua C.
GC, Chief Compliance Officer
AWARD30,000 sh
Mar 4, 2026
Lee Joshua C.
GC, Chief Compliance Officer
AWARD400,000 sh
Mar 4, 2026
Plavan Matthew T
CFO and COO
AWARD32,000 sh
Mar 4, 2026
Plavan Matthew T
CFO and COO
AWARD500,000 sh
Mar 4, 2026
Bissell John
CEO and Director
AWARD500,000 sh
Mar 4, 2026
Bissell John
CEO and Director
AWARD60,000 sh

Earnings setup

Estimates
Nov 11
reports in 16 days
PeriodEPS est.Range30D rev.Revenue
Next FY———$0.00
Current FY———$0.00
Next Q———$0.00
Current Q———$0.00

Short side

FINRA· Jun 30, 2026
206,276
shares short
-32.7%
vs prior settlement
1.9
days to cover
≈3.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 12, 2026 Earnings calendar
ORGN Q2 2026 Earnings Scheduled — 2026-08-12
Jul 10, 2026 SEC
Origin Materials has received effectiveness on two shelf registration statements (File Nos. 333-289615 and 333-257931)…
EFFECT — Impact 6/10
Jun 30, 2026 Inst.
ROYAL BANK OF CANADA — ADD
11 shares (—)
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — TRIM
45,892 shares ($45.4K)
Jun 23, 2026 SEC
Nasdaq filed a Form 25-NSE to delist and deregister Origin Materials' warrants under Rule 12d2-2(a)(2), effective…
25-NSE — Impact 8/10
Mar 4, 2026 Insider
Lee Joshua C. was granted 30,000 shares
GC, Chief Compliance Officer
Mar 4, 2026 Insider
Lee Joshua C. was granted 400,000 shares
GC, Chief Compliance Officer
Mar 4, 2026 Insider
Plavan Matthew T was granted 32,000 shares
CFO and COO
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

SecBot reports

2 filings · 0 bullish · 2 bearish
All ORGN filing & press-release reports (2)